Filter By Industry
Filter By Tag

Newsroom

Lavenhill Securities Limited Press releases

1 - 1 of 1 Press Release

Bristol Myers Squibb Buys RayzeBio, Second Billion-Dollar Offer in Days. - Lavenhill Securities
Jan 11, 2024
RayzeBio Inc. (RYZB) shares soared Tuesday after Bristol Myers Squibb Co. (BMY) announced a $4.1 billion acquisition of the radiopharmaceutical therapy business to extend its cancer treatment choices.


Lavenhill Securities Limited RSS Feed